PubMed HealthSearch

Biomedical subjects

S J Wells

Publications and source records attributed to S J Wells.

15 recordsLinked to original sources

Image cytometric comparison of proliferating cell nuclear antigen and MIB-1 staining in hepatocellular carcinoma and adjacent liver tissue.

Studies of cellular proliferation may aid in elucidation of mechanisms of hepatocarcinogenesis and provide potential prognostic information in cases of hepatocellular carcinoma. Increased proliferation has been reported in the liver tissue adjacent to hepatocellular carcinoma and may be a risk factor for recurrence after tumor resection. We quantitated proliferating cell nuclear antigen (PCNA) clone PC10 and MIB-1 nuclear immunostain by image cytometry in fixed, paraffin-embedded tissue sections of normal, cirrhotic, and dysplastic livers with and without co-existent hepatocellular carcinoma and in the hepatocellular carcinoma. Fifteen high power fields were analyzed in each case using the CAS 200 image analyzer and results were expressed as the percent positive nuclear area. Cirrhotic liver showed significantly less proliferation adjacent to hepatocellular carcinoma than without hepatocellular carcinoma. There was a similar, but not significant, tendency for dysplastic liver. Increasing mean proliferation was noted from normal to cirrhotic to dysplastic liver to low grade to high grade hepatocellular carcinoma. These findings were similar using both PC10 and MIB-1. There tended to be slightly more staining with PC10 than with MIB-1, but the mean percent positive nuclear area was significantly greater with PC10 only in high grade hepatocellular carcinoma. Comparison of individual cases, however, yielded significant correlation between the two antibodies in the low grade and high grade hepatocellular carcinomas, but not in the benign livers. These findings demonstrate that image cytometric quantitation of PC10 and MIB-1 immunostain may be comparable measures of cellular proliferation and that there is no increase in proliferation in the hepatic tissue adjacent to hepatocellular carcinoma.

Antibodies, Monoclonal

Reverse transcriptase-polymerase chain reaction for bcr/abl fusion in chronic myelogenous leukemia.

Reverse transcriptase-polymerase chain reaction (RT-PCR) has shown promise as a means of detecting low levels of cells bearing the Philadelphia chromosome (Ph1) and for detecting cytogenetically inapparent ("masked") Ph1 in patients with chronic myelogenous leukemia (CML). For detection by karyotyping, dividing cells must be used, precluding use of peripheral blood samples in cases with low peripheral blood blast counts. Reverse transcriptase-polymerase chain reaction was performed in 83 bone marrow and 30 peripheral blood samples from patients with CML to compare results with karyotyping and to evaluate utility of this test on peripheral blood samples. Using isolated total cellular RNA and a single primer pair, cDNA was transcribed, amplified, electrophoresed, and probed for bcr/abl fusion involving M-bcr exons 2 and 3 of the bcr gene. Fifty-three samples were from untreated or conventionally treated patients (pre-BMT), and 60 were from patients who had undergone bone marrow transplantation (post-BMT). Fifty of 53 pre-BMT samples were positive by RT-PCR. Two samples, negative by RT-PCR, had complex translocations, t(9;16;22) and t(4;14;22). One case was indeterminate by RT-PCR, but positive on retesting. Forty-five of 53 had Ph1 by karyotyping; 8 were negative, including 5 peripheral blood samples, 2 bone marrow samples with "masked" Ph1, and 1 bone marrow sample with poor growth. Thirty-five of 60 post-BMT samples were positive by RT-PCR. Fourteen of 60 post-BMT samples had Ph1 by karyotyping. Of the RT-PCR+/Ph1- cases, most showed a weak but definite band by RT-PCR, suggesting a low level of the bcr/abl fusion gene. Nineteen patients had concurrent peripheral blood and bone marrow samples analyzed by RT-PCR and karyotyping. Of 16 patients with satisfactory RNA extraction, 15 had concordant results by RT-PCR. Five patients had adequate metaphase cells for karyotypic analysis. All had Ph1 in bone marrow, but were negative in peripheral blood. Our results indicate that RT-PCR for detection of bcr/abl fusion is more sensitive than karyotyping in pre- and post-BMT samples. Furthermore, RT-PCR can be successfully performed on peripheral blood, yielding excellent correlation with bone marrow samples.

Base Sequence

CD117/CD34 expression in leukemic blasts.

CD117 is a transmembrane protein receptor encoded by the c-kit proto-oncogene. The CD117 ligand is stem cell factor, an important hematopoietic regulator. CD117 is present on approximately 4% of normal bone marrow mononuclear cells and in acute myelogenous leukemia (AML) and chronic myelogenous leukemia in myeloid blast crisis, but rarely in acute lymphoblastic leukemia (ALL). Initially viewed as a primitive myeloid marker, CD117 has been identified in all FAB subtypes of AML and may predict poor outcome. CD34, a primitive stem cell marker, may also predict poor outcome. The aim of this study was to examine the relationship between CD117 and CD34 expression on leukemic blasts and to determine whether CD117 is related to lymphoid-associated antigen (LAA) expression in AML. Consecutive bone marrow samples were studied from cases of AML (30 cases), myelodysplastic syndromes (MDS) (4 cases), myeloproliferative disorders in blast crisis (MPD-BC) (6 cases), and ALL (5 cases). Cases were diagnosed according to FAB criteria and included M0 (3 cases), M1 (2 cases), M2 (13 cases), M3 (1 case), M4 (6 cases), M5 (3 cases), M6 (1 case), AML NOS (1 case), RAEB (3 cases), and RAEB-T (1 case). CD117 and CD34 were analyzed by multiparameter flow cytometry. Blasts in 10 de novo AML samples were CD117+/CD34+ in 4 cases, CD117+/CD34-in 3 cases, CD117-/CD34+ in 1 case, and CD117-/ CD34- in 2 cases. Blasts in 20 cases of relapsed AML were CD117+/ CD34+ in 13 cases, CD117+/CD34- in 6 cases, and CD117-/CD34+ in 1 case. Blasts in MDS were CD117+/CD34+ in 3 cases, CD117-/ CD34+ in 1 case. Blasts in MPD-BC were CD117+/CD34+ in 4 cases, CD117-/CD34+ in 2 cases. Blasts in ALL were CD117+/CD34+ in 1 case, CD117-/CD34+ in 1 case, CD117-/CD34- in 3 cases. Of 26 cases of CD117+ AML, CD4 was expressed in 15 (58%) cases, CD7 in 7 (27%) cases, and CD2 in 2 (8%) cases. CD117/CD34 expression did not correlate with FAB subtype of AML. CD117 is borne on most leukemic blasts of myeloid origin (in this study, 87% of AML, 80% of MPD-myeloid BC, and 75% of MDS) and does not exclude expression of LAA. Although CD117 is a receptor for stem cell factor, its expression does not appear to correlate with CD34 positivity.

Adolescent

Risk factors for fecal shedding of Escherichia coli O157:H7 in dairy calves.

A case-control study was conducted to determine risk factors for fecal shedding of Escherichia coli O157:H7 (ECO) in dairy calves. Three herds previously found to lack calves that shed ECO in their feces were selected for each herd previously found to have calves that shed ECO. Fecal samples from 965 calves on 64 farms were tested for ECO by microbial culture. Sample prevalence of ECO in calves less than 8 weeks old was 1.4% and in calves 8 weeks or older was 4.8%. Calves were 3 times more likely to shed ECO after weaning than before weaning. Shedding of ECO was associated with grouping calves before weaning; feeding whole cottonseed was negatively associated with ECO shedding. The change in results between testing periods illustrated that an individual herd's status cannot be defined by a single testing of a small sample of cattle.

Age Factors

Some risk factors associated with clinical lameness in dairy herds in Minnesota and Wisconsin.

An observational study of the relationships between clinical lameness and herd-level risk factors was made in 18 dairy herds in Minnesota and Wisconsin. Lameness in the lactating cows was assessed by two observers during herd visits made in the summer of 1989 and the spring of 1990, using a uniform scoring system. A questionnaire was used to obtain information about the general management, routine hoof care, nutrition, housing and flooring on the farms. Factors associated with the prevalence of clinical lameness in the summer included stall moisture, the size of the exercise area for the lactating cows and the amounts of dry concentrates and fresh forages fed to them. Factors associated with clinical lameness in the spring included the use of parlour milking facilities and the frequency with which the rations for the lactating cows were balanced.

Animal Feed

Management factors related to Salmonella shedding by dairy heifers.

In a national survey of dairy operations with > or = 30 milking cows, fecal samples from 6861 preweaned dairy heifer calves on 1063 operations were tested for Salmonella. One hundred forty-five (2.1%) of the fecal samples from 79 (7.4%) of the farms tested positive for Salmonella. A multivariate logistic regression model revealed that medicated milk replacer and hay fed to dairy heifers from 24 h of age until weaning were associated with a reduced risk of Salmonella sheddings, as was calving in an individual animal area within a building.

Animal Feed

A study of the use of milk replacers for dairy calves in the United States.

This study focused on aspects of the National Dairy Heifer Evaluation Project that involved neonatal feeding practices and types of milk replacers utilized on dairy farms. Types of milk replacers and the management practices associated with their feeding were studied. Nearly 60% of US dairy farms use milk replacers for some or all of the feeding program for neonatal calves. Regional differences existed in the types of liquid feeds and milk replacers fed to calves. Western producers fed less milk replacer, and western and northeast producers fed replacers with less total CP. Many characteristics of management utilized along with these products reflect accepted management and nutrition practices. During the study period from 1991 to 1992, 11.2% of replacers contained casein. A greater proportion of these were found in the West during the first 6 mo of the study, reflecting changes in the milk replacer formulations during that time.

Animal Feed

Effect of long-term administration of a prolonged release formulation of bovine somatotropin (sometribove) on clinical lameness in dairy cows.

A matched case-control study design was used to assess the effects of long-term administration of a prolonged release formulation of bovine somatotropin (sometribove) on clinical lameness and limb lesions in dairy cows. Cows treated with sometribove for at least 2 lactations (cases) and nontreated dairy cows matched by herd, parity, age, and stage of lactation (controls) in 8 herds were evaluated for clinical lameness (as assessed by gait abnormality) and limb lesions by 2 observers, using a standardized scoring procedure at a single herd visit. Although a high proportion of the study cows were clinically lame (43%), an association was not detected between chronic administration of sometribove and prevalent lameness. Of 21 types of limb lesions identified, 2 were positively associated and 2 were negatively associated with long-term sometribove use. Superficial laceration of the tarsus (odds ratio [OR] = 2.1) and superficial swelling of the metatarsophalangeal joint (OR = 4.5) were positively associated with sometribove treatment, whereas femoral lesions (OR = 0.2) and superficial lacerations of the femur (OR = 0.14) were negatively associated with sometribove treatment.

Age Factors

Ability of laboratory methods to predict in-use efficacy of antimicrobial preservatives in an experimental cosmetic.

The abilities of nine antimicrobial systems to preserve an experimental water-based cosmetic formulation were evaluated by six microbiological challenge tests: the U.S. Pharmacopeia test; the British Pharmacopeia test; the Cosmetic, Toiletry, and Fragrance Association test; the rapid screen test; the sequential challenge test; and the post-use test. The antimicrobial systems contained various combinations and amounts of two parabens and a quaternary compound in order to provide a broad range of preservation. The results obtained were compared with the abilities of the formulations to support maintenance and growth of microorganisms in microfloras obtained from human axilla areas and finger skin during an 8-week simulated in-use test. Without statistical analysis all of the tests predicted the results obtained with well-preserved or poorly preserved formulations. The rapid screen test was the best test for predicting differences at intermediate levels of preservation. Statistically, all of the tests were equivalent predictors of preservation efficacy in the in-use test (P = 0.05). At the P = 0.10 level, only the U.S. Pharmacopeia, British Pharmacopeia, rapid screen, Cosmetic, Toiletry, and Fragrance Association tests were significantly predictive. The results of prediction by a test, based on the preservative levels used, agreed well with the in-use test results (P = 0.01). A total of 20% of the formulations that contained excessive microbial levels contained human axilla microorganisms. The levels of preservation in failed products were similar to the levels of preservation in unused controls.

Axilla

The National Dairy Heifer Evaluation Project: a profile of heifer management practices in the United States.

The National Dairy Heifer Evaluation Project was a cooperative, USDA-sponsored project involving state agricultural departments, the Cooperative Extension Service, the National Agricultural Statistics Service, and the Animal and Plant Health Inspection Service. A series of retrospective and prospective descriptive surveys using a multiple list and area frame sampling technique were conducted. Information collected pertained primarily to dairy neonates and replacement heifers. Much of the study was related to observational information on health and management characteristics that can be related to the animals' long-term physical and economic performance. The data reflect herds representing 78% of the national dairy cow population. Average herd size was 86 milking and dry cows and 66 heifers. Many characteristics of these herds reflect accepted and recommended practices in the area of dairy replacement management and nutrition. Data summarized in this national study can be utilized to evaluate the impact of management practices on dairy operations.

Animal Nutritional Physiological Phenomena

Prevalence and severity of lameness in lactating dairy cows in a sample of Minnesota and Wisconsin herds.

An epidemiologic study investigating the prevalence of lameness in lactating dairy cows was performed in 17 dairy herds in Minnesota and Wisconsin. The mean herd size was 50 cows. Cows from 14 herds were housed in stanchions or tie stalls, and cows from 3 herds in free stalls or dry lot. During visits to each farm in the summer and subsequent spring, 2 investigators simultaneously but independently evaluated the ambulation of lactating cows by use of a standardized scoring system. The lameness scoring system was reliable at the 2 visits, with 92.7 and 91.3% agreement between the 2 observers and kappa coefficients of 0.60. The prevalence of lameness detected by the investigators ("clinical" lameness) was 13.7% (117/853) in summer and 16.7% (134/801) in spring in lactating dairy cows. These prevalences were 2.5 times higher than those estimated by the herd managers. Parity was significantly (P < or = 0.03) associated with lameness, with higher prevalence of clinical lameness found in cows of higher parity.

Animals

Alternative sources of hematopoietic stem cells for bone marrow transplantation and rescue.

Hematopoietic stem cells from sources other than medullary bone marrow are being used for experimental and clinical rescue following myeloablative therapy. In this paper we review the cells capable of bone marrow engraftment and the use of orthotopic, cadaveric, peripheral blood, umbilical cord blood, and fetal liver derived stem cells in transplantation.

Blood Cells

Association between clinical lameness and Borrelia burgdorferi antibody in dairy cows.

Results of an ELISA, indirect fluorescent antibody (IFA) test, and immunoblot analysis (western blotting) for antibody to Borrelia burgdorferi in a sample of 216 lactating dairy cows were compared. The microscopic microtitration agglutination test for antibody to 6 serovars of Leptospira interrogans was also performed to evaluate possible cross-reactivity between B burgdorferi and L interrogans. Using western blotting as the standard test against which the ELISA and IFA test were compared, the ELISA had greater sensitivity (50% in summer and 38% in spring) with similar specificity (83 and 82%), compared with the IFA test (sensitivity, 6 and 5%; specificity, 90 and 83%). In addition, seropositivity to B burgdorferi, using the ELISA, was not found to be associated with seropositivity to L interrogans serovars. A matched case-control study evaluating the association between clinical lameness and antibody to B burgdorferi was performed in lactating dairy cows of 17 Minnesota and Wisconsin herds. Sera from case and control cows matched by herd, parity, and stage of lactation were evaluated, using an ELISA for B burgdorferi antibody during 2 seasons. High B burgdorferi antibody values were associated with clinical lameness in dairy cows (P = 0.006 in summer and P = 0.04 in spring).

Animals

Child protective services: research for the future.

The legal context of child protective services provides the framework for all inquiries and knowledge-building in the field. From this foundation, it is possible to analyze the definition of a child protective services case, describe who is served by the system, evaluate current system functioning, and identify outcome measures. Future research should address formative questions such as the development of consistent definitions of maltreatment and evaluation of service delivery. Evaluation should include measuring treatment outcomes as well as examining the functioning and management of the system.

Child